Meta análisis Testosterona y riesgo cardiovascular

Foro general ciencia, medicina, nutrición, salud pública, política

Moderador: Fisio

Meta análisis Testosterona y riesgo cardiovascular

Notapor Fisio » Mié, 02 Abr 2014, 00:34

No parece existir una asociación clara en tre el uso de testosterona y enfermedad cardiovascular. Obviamente no son los niveles de testosterona usados en culturismo y deportes de fuerza.

Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.

To conduct a systematic review and meta-analysis of randomized trials that assessed the effect of testosterone use on cardiovascular events and risk factors in men with different degrees of androgen deficiency.
METHODS:

Librarian-designed search strategies were used to search the MEDLINE (1966 to October 2004), EMBASE (1988 to October 2004), and Cochrane CENTRAL (inception to October 2004) databases. The database search was performed again in March 2005. We also reviewed reference lists from included studies and content expert files. Eligible studies were randomized trials that compared any formulation of commercially available testosterone with placebo and that assessed cardiovascular risk factors (lipid fractions, blood pressure, blood glucose), cardiovascular events (cardiovascular death, nonfatal myocardial infarction, angina or claudication, revascularization, stroke), and cardiovascular surrogate end points (ie, laboratory tests indicative of cardiac or vascular disease). Using a standardized data extraction form, we collected data on participants, testosterone administration, and outcome measures. We assessed study quality with attention to allocation concealment, blinding, and loss to follow-up.
RESULTS:

The 30 trials included 1642 men, 808 of whom were treated with testosterone. Overall, the trials had limited reporting of methodological features that prevent biased results (only 6 trials reported allocation concealment), enrolled few patients, and were of brief duration (only 4 trials followed up patients for > 1 year). The median loss to follow-up across all 30 trials was 9%. Testosterone use in men with low testosterone levels led to inconsequential changes in blood pressure and glycemia and in all lipid fractions (total cholesterol: odds ratio [OR], -0.22; 95% confidence interval [CI], -0.71 to 0.27; high-density lipoprotein cholesterol: OR, -0.04; 95% CI, -0.39 to 0.30; low-density lipoprotein cholesterol: OR, 0.06; 95% CI, -0.30 to 0.42; and triglycerides: OR, -0.27; 95% CI, -0.61 to 0.08); results were similar in patients with low-normal to normal testosterone levels. The OR between testosterone use and any cardiovascular event pooled across trials that reported these events (n = 6) was 1.82 (95% CI, 0.78 to 4.23). Several trials failed to report data on measured outcomes. For reasons we could not explain statistically, the results were inconsistent across trials.
CONCLUSION:

Currently available evidence weakly supports the inference that testosterone use in men is not associated with important cardiovascular effects. Patients and clinicians need large randomized trials of men at risk for cardiovascular disease to better inform the safety of long-term testosterone use.


http://www.ncbi.nlm.nih.gov/pubmed/17285783
Avatar de Usuario
Fisio
Administrador del Sitio
 
Mensajes: 4441
Registrado: Dom, 01 Sep 2013, 14:18

Re: Meta análisis Testosterona y riesgo cardiovascular

Notapor Sergio » Mar, 02 Sep 2014, 10:36

Tenemos en Europa algo parecido al TRT (testosterone replacement therapy) tan popular en USA? No veo mala idea a partir de los 40-50 poder suplementarse legalmente con testosterone para paliar el bajón de los niveles al envejecer.
Sergio
 
Mensajes: 125
Registrado: Sab, 21 Sep 2013, 02:15
Ubicación: Helsinki, Finlandia

Re: Meta análisis Testosterona y riesgo cardiovascular

Notapor Valanor » Mié, 03 Sep 2014, 00:21

Yo es algo que se muy seguro que voy a hacer en cuanto llegue a cierta edad, asi que llegado el momento ya veremos que es lo mas seguro y efectivo.
Código de descuento iHerb: JGJ833
Código de descuento Myprotein: MP27139542
Código de descuento Powdercity: http://powdercity.refr.cc/46RWDWL
Avatar de Usuario
Valanor
 
Mensajes: 217
Registrado: Mié, 25 Sep 2013, 19:39
Ubicación: Barcelona

Re: Meta análisis Testosterona y riesgo cardiovascular

Notapor Fisio » Mar, 09 Sep 2014, 04:43

Ya veremos, quizás haya recelo porque la terapia hormonal en mujeres aumentó los casos de cancer.
Avatar de Usuario
Fisio
Administrador del Sitio
 
Mensajes: 4441
Registrado: Dom, 01 Sep 2013, 14:18


Volver a Muscleblog

¿Quién está conectado?

Usuarios navegando por este Foro: Majestic-12 [Bot] y 3 invitados
cron